Exact Mass: 228.1474

Exact Mass Matches: 228.1474

Found 60 metabolites which its exact mass value is equals to given mass value 228.1474, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Leucylproline

(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


Leucylproline is a dipeptide composed of leucine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411). A dipeptide found in urine (PMID: 3782411). This is a proteolytic breakdown product of larger proteins. [HMDB]

   

Isoleucylproline

(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


Isoleucylproline is a dipeptide composed of isoleucine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411).

   

N,N,N-Trimethyl-L-alanyl-L-proline betaine

(2S)-1-[(2S)-2-(trimethylazaniumyl)propanoyl]pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


N,N,N-Trimethyl-L-alanyl-L-proline betaine (TMAP) belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. TMAP was previously an unknown potential plasma biomarker for glomerular filtration rate (GFR) but its structure has since been elucidated (PMID: 28706470). TMAP has also been identified as a potential plasma biomarker of reduced kidney function in early chronic kidney disease (CKD), end stage renal disease (ESRD), and hemodialytic clearance (PMID: 31048706).

   

Pro-leu

2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-4-methylpentanoic acid

C11H20N2O3 (228.1474)


   

Pro-Ile

(2S,3S)-2-({hydroxy[(2S)-pyrrolidin-2-yl]methylidene}amino)-3-methylpentanoic acid

C11H20N2O3 (228.1474)


   

MCULE-3665705986

MCULE-3665705986

C11H20N2O3 (228.1474)


   

MCULE-2919364138

MCULE-2919364138

C11H20N2O3 (228.1474)


   

L-Prolyl-L-leucin-anhydrid|Prolyl-leucyl-anhydrid

L-Prolyl-L-leucin-anhydrid|Prolyl-leucyl-anhydrid

C11H20N2O3 (228.1474)


   

tert-butyl 2-carbamoylpiperidine-1-carboxylate

tert-butyl 2-carbamoylpiperidine-1-carboxylate

C11H20N2O3 (228.1474)


   

alpha-Methyldethiobiotin

alpha-Methyldethiobiotin

C11H20N2O3 (228.1474)


   

(2S,3S)-3-Methyl-2-((S)-pyrrolidine-2-carboxamido)pentanoic acid

(2S,3S)-3-Methyl-2-((S)-pyrrolidine-2-carboxamido)pentanoic acid

C11H20N2O3 (228.1474)


   

Pro-Leu

H-Pro-Leu-OH

C11H20N2O3 (228.1474)


A dipeptide formed from L-proline and L-leucine residues.

   

L-Prolyl-L-isoleucine

L-Prolyl-L-isoleucine

C11H20N2O3 (228.1474)


   

Leucylproline

Leucylproline

C11H20N2O3 (228.1474)


Annotation level-3

   
   
   
   
   

1-L-Leucyl-L-proline

1-L-Leucyl-L-proline

C11H20N2O3 (228.1474)


   

Ile-pro

L-Isoleucyl-L-proline

C11H20N2O3 (228.1474)


A dipeptide formed from L-isoleucine and L-proline residues.

   

N-Boc-D-2-Piperidinecarboxamide

N-Boc-D-2-Piperidinecarboxamide

C11H20N2O3 (228.1474)


   

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate

C11H20N2O3 (228.1474)


   

(S)-1-BOC-3-PIPERIDINECARBOXAMIDE

(S)-1-BOC-3-PIPERIDINECARBOXAMIDE

C11H20N2O3 (228.1474)


   

tert-butyl 4-(2-oxoethyl)piperazine-1-carboxylate

tert-butyl 4-(2-oxoethyl)piperazine-1-carboxylate

C11H20N2O3 (228.1474)


   

(R)-1-BENZYL-BETA-PROLINOL

(R)-1-BENZYL-BETA-PROLINOL

C11H20N2O3 (228.1474)


   

ethyl 1-(dimethylcarbamoyl)piperidine-2-carboxylate

ethyl 1-(dimethylcarbamoyl)piperidine-2-carboxylate

C11H20N2O3 (228.1474)


   

2-Methyl-2-propanyl 9-oxa-3,7-diazabicyclo[3.3.1]nonane-3-carboxy latato

2-Methyl-2-propanyl 9-oxa-3,7-diazabicyclo[3.3.1]nonane-3-carboxy latato

C11H20N2O3 (228.1474)


   

1-ETHYL-4-(TERT-BUTYLOXYCARBONYL)PIPERAZIN-2-ONE

1-ETHYL-4-(TERT-BUTYLOXYCARBONYL)PIPERAZIN-2-ONE

C11H20N2O3 (228.1474)


   

(S)-1-Boc-N-Methylpyrrolidine-2-carboxamide

(S)-1-Boc-N-Methylpyrrolidine-2-carboxamide

C11H20N2O3 (228.1474)


   

(R)-tert-Butyl (2-oxoazepan-3-yl)carbamate

(R)-tert-Butyl (2-oxoazepan-3-yl)carbamate

C11H20N2O3 (228.1474)


   

1-Butyl-3-Methylimidazolium (L)-Lactate

1-Butyl-3-Methylimidazolium (L)-Lactate

C11H20N2O3 (228.1474)


   

7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane

7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane

C11H20N2O3 (228.1474)


   

(S)-tert-Butyl (2-oxoazepan-3-yl)carbamate

(S)-tert-Butyl (2-oxoazepan-3-yl)carbamate

C11H20N2O3 (228.1474)


   

tert-butyl (3S)-3-acetamidopyrrolidine-1-carboxylate

tert-butyl (3S)-3-acetamidopyrrolidine-1-carboxylate

C11H20N2O3 (228.1474)


   

(+/-)-N-Alpha-Boc-Amino-Epsilon-Caprolactam

(+/-)-N-Alpha-Boc-Amino-Epsilon-Caprolactam

C11H20N2O3 (228.1474)


   

ethyl 1-(dimethylcarbamoyl)piperidine-4-carboxylate

ethyl 1-(dimethylcarbamoyl)piperidine-4-carboxylate

C11H20N2O3 (228.1474)


   

N-Boc-DL-2-piperidinecarboxamide

N-Boc-DL-2-piperidinecarboxamide

C11H20N2O3 (228.1474)


   

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate

tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate

C11H20N2O3 (228.1474)


   

tert-Butyl 4-carbamoylpiperidine-1-carboxylate

tert-Butyl 4-carbamoylpiperidine-1-carboxylate

C11H20N2O3 (228.1474)


   

(s)-1-n-boc-piperidine-2-carboxamide

(s)-1-n-boc-piperidine-2-carboxamide

C11H20N2O3 (228.1474)


   

1-Boc-3-Carbamoylpiperidine

1-Boc-3-Carbamoylpiperidine

C11H20N2O3 (228.1474)


   

4-{[(Cyclohexylamino)carbonyl]amino}butanoic acid

4-{[(Cyclohexylamino)carbonyl]amino}butanoic acid

C11H20N2O3 (228.1474)


   

Prolylisoleucine

Prolylisoleucine

C11H20N2O3 (228.1474)


   

1-(2-Amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid

1-(2-Amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


   

N-L-Prolyl-L-isoleucine

N-L-Prolyl-L-isoleucine

C11H20N2O3 (228.1474)


   

(2S)-1-[(2S)-2-azaniumyl-4-methylpentanoyl]pyrrolidine-2-carboxylate

(2S)-1-[(2S)-2-azaniumyl-4-methylpentanoyl]pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


   
   

(2S)-4-methyl-2-[[(2S)-pyrrolidin-1-ium-2-carbonyl]amino]pentanoate

(2S)-4-methyl-2-[[(2S)-pyrrolidin-1-ium-2-carbonyl]amino]pentanoate

C11H20N2O3 (228.1474)


   

1-(2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxylic acid

1-(2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxylic acid

C11H20N2O3 (228.1474)


   

Leu-Pro zwitterion

Leu-Pro zwitterion

C11H20N2O3 (228.1474)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Leu-Pro.

   

Pro-Ile

Pro-Ile

C11H20N2O3 (228.1474)


A dipeptide formed from L-proline and L-isoleucine residues.

   

Isoleucyl-proline

Isoleucyl-proline

C11H20N2O3 (228.1474)


   

Leu-pro

Leu-pro

C11H20N2O3 (228.1474)


A dipeptide formed from L-leucine and L-proline residues.

   

N,N,N-Trimethyl-alanylproline betaine

N,N,N-Trimethyl-alanylproline betaine

C11H20N2O3 (228.1474)


   

n-[2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

n-[2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

C11H20N2O3 (228.1474)


   

2-amino-4-methylpentanoyl pyrrolidine-2-carboxylate

2-amino-4-methylpentanoyl pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


   

n-[(2z)-2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

n-[(2z)-2-(hydroxyimino)-4-methylpentanoyl]-3-methylbutanimidic acid

C11H20N2O3 (228.1474)


   

(2s)-2-amino-4-methylpentanoyl (2s)-pyrrolidine-2-carboxylate

(2s)-2-amino-4-methylpentanoyl (2s)-pyrrolidine-2-carboxylate

C11H20N2O3 (228.1474)


   

6-(2-hydroxy-5-methyl-4,5-dihydro-3h-imidazol-4-yl)-2-methylhexanoic acid

6-(2-hydroxy-5-methyl-4,5-dihydro-3h-imidazol-4-yl)-2-methylhexanoic acid

C11H20N2O3 (228.1474)


   

(3s,6s)-3-[(2s)-butan-2-yl]-6-(3-hydroxypropyl)-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(2s)-butan-2-yl]-6-(3-hydroxypropyl)-3,6-dihydropyrazine-2,5-diol

C11H20N2O3 (228.1474)